Objectives: This study aims to find a relationship between secondary metabolites of akar kuning and neuraminidase (NA) with molecular docking study and also to determine the most potent NA inhibitor from metabolites of akar kuning. Methods: All ligands were sketched and optimized using Gaussian 03W with Hartree-Fock method basis sets 6-311G. Molecular docking was performed using AutoDock 4.2.6 toward NA in complexes with oseltamivir, a known NA inhibitor as a co-crystal ligand. The main parameter used was the free energy of binding (ΔG) and dissociation constant (K i ) as affinity marker. Pharmacophore optimization was conducted on metabolite with the highest affinity to assess the main pharmacophore with the highest influence. Results: Fibleucin provided the most negative ΔG and the lowest K i toward NA with -8.12 kcal/mol and 1.11 µM, respectively. Further pharmacophore optimization of fibleucin reveals that ether group at position number 25 had the highest influence toward fibleucin affinity and might be considered as the main pharmacophore of fibleucin as NA inhibitor. Conclusion: in silico molecular docking and pharmacophore optimization results indicated that fibleucin could be considered as NA inhibitor and should be potential to be developed as antiinfluenza particularly to H5N1 with oseltamivir resistance.
I. INTRODUCTION
The battle against avian influenza seems to have been won by mankind with the discovery of various neuraminidase (NA) inhibitors, including oseltamivir and zanamivir [1] . Not only fully synthesis compounds, several natural products such as artemisinin derivatives from Artemisia annua also proved to have potential to be developed as NA inhibitors [2] . The discovery not only could reduce the resistance of anti-avian influenza drugs but also open up opportunities to optimize the potential of various derivatives from other natural products, especially against oseltamivir resistance avian influenza H5N1 [3] .
Akar kuning (Arcangelisia flava), endemic plants from Borneo especially known for have many pharmacology potentials, including as antiviral [4] . Akar kuning was known for containing various bioactive compounds, one of the most famous of which is berberine.
However, akar kuning still contains many secondary metabolites which potentially have effects as NA inhibitor [5] .
Despite have the potential, not every ligand worth to be further researched. The only ligand with good affinity could be further optimized until fit enough to be developed as NA inhibitor [6] . Optimization of the selected ligand can be done in several ways, one of them by pharmacophore modification from test ligand [7] . The discovery of the main pharmacophore with the greatest influence on the affinity of a ligand is performed by deletion of each pharmacophore from a ligand one by one [8] . The modification results then examined with docking method to assess the influence of deleted pharmacophore [9] .
In this study, we conducted in silico study to determine the most potent secondary metabolites of akar kuning as NA inhibitor and could be developed on anti-influenza especially H5N1 therapy using molecular docking method [2] . We also make pharmacophore modifications of the selected ligand with the highest affinity to determine the main pharmacophore with the highest influence as NA inhibitor. Institute was used as docking software [12] .
II. METHODS AND PROCEDURE

Preparation of ligands and receptor
The structure of NA H5N1 in complexes with oseltamivir (protein data bank ID 2HU4) was obtained from website www.rscb.org with the binding site of oseltamivir chosen as active site since this site already known for NAI development [13] .
Validation of docking process
The method used for molecular docking validation was pose selection using co-crystal structure by redocking it into the active site of NA. Thus, redocking was performed with oseltamivir as co-crystal ligand on NA active site [7] . The parameters observed were rootmean-square deviation (RMSD) of co-crystal ligand at the selected binding site [14] .
Software for molecular docking is preferred to predict results from experimental poses with RMSD score no more than 2 Å. Smaller RMSD score indicates that position of the redocking ligand was closer to crystallography ligand result [15] .
Molecular docking studies
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Molecular docking for all test ligands was performed in a similar way as validation process using with similar grid box size and position [16] . The parameter used in docking process was the free energy of binding (ΔG), dissociation constant (K i ), amino acids residues, and number of hydrogen bonds.
Ligand affinity toward receptor in docking method was determined by ΔG and K i scores.
More negative ΔG and lower K i indicated higher ligand affinity toward active site of the receptor [17] . Test ligand with the highest affinity was compared with validation result of co-crystal ligand in the active site to determine the potency of test ligand as NAI [18] .
Pharmacophore optimization
Selected test ligand with the highest affinity toward active site of NA is then pharmacophore optimized to assess
III. RESULTS
All test ligands were sketched and geometry optimized as shown in 
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Fibleucin-6 (FLC-6)
All fibleucin derivatives were geometry optimized using Hartree-Fock method basis oseltamivir [18] .
The comparisons could be seen in figure 2 . 
IV. DISCUSSION
All test ligands were sketched and geometry optimized with Hartree-Fock method with basis set 6-311G for geometry optimization.
This method was ab initio approximation with relatively high confidence rate [10] . Docking validation was done with redocking method at the active site of NA receptor using AutoDock 4.2.6. All parameters were set to default protocol except for numbers of genetic algorithms runs which set to 100 runs to improve the accuracy of docking result [19] .
Although almost, the result was still considered as valid for molecular docking purpose.
All test ligands provided negative scores of ΔG in different ranges, with fibleucin had the most negative score. However, the score itself still below oseltamivir as co-crystal ligand. properties on the affinity of fibleucin against NA receptor.
